Followers | 33 |
Posts | 4692 |
Boards Moderated | 0 |
Alias Born | 06/02/2010 |
Tuesday, May 23, 2017 2:24:17 PM
1. Increase in revenues was a bit of a mirage as the previous quarter only counted partial months of labs operating after acquisition, etc.
2. A lot of buying has been fueled by inflated expectations, many of them claimed by posts on this board. Buy the rumor, sell the news!
3. An unrealistic valuation based upon an O/S that hasn't taken into proper consideration all of the potential dilution from preferred shares. SGBY may be doing well in some sense, but there are too many boatloads of shares to support a higher price.
4. I mentioned the possibility this morning of dilution from notes that came due this last week. Nobody seemed to care or respond to that notion. People not doing their DD or in denial or in some cases just trying to fool folks into buying so that they can sell.
OR- the whole investing universe is stupid and there are no reasons why the share price isn't higher.
In the meantime SGBY will try to build a new base and wait for new acquisitions that can have a meaningful impact on revenues.
GLTY
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM